NFATC2 and acute myeloid leukemia: In this study, we have identified NFATC2 as a novel player in AML cell pathobiology, downstream of the histone demethylase KDM4A, which has previously been characterised as a master regulator of oncogenesis in AML cells, and highlighted the role of MYC as a potential co‐regulatory gene.